These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1488 related articles for article (PubMed ID: 28746884)

  • 1. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential Combined Effect of Phages and Antibiotics on the Inactivation of
    Lopes A; Pereira C; Almeida A
    Microorganisms; 2018 Dec; 6(4):. PubMed ID: 30563133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples.
    Pereira S; Pereira C; Santos L; Klumpp J; Almeida A
    Virus Res; 2016 Jan; 211():199-208. PubMed ID: 26541317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota.
    Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS
    Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of phage therapy: Synergistic effect of phage EcSw (ΦEcSw) and antibiotic combination towards antibiotic-resistant Escherichia coli.
    Easwaran M; De Zoysa M; Shin HJ
    Transbound Emerg Dis; 2020 Nov; 67(6):2809-2817. PubMed ID: 32453904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli.
    Pereira C; Moreirinha C; Lewicka M; Almeida P; Clemente C; Romalde JL; Nunes ML; Almeida A
    Virus Res; 2017 Jan; 227():171-182. PubMed ID: 27756632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria.
    Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H
    Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scoping the effectiveness and evolutionary obstacles in using plasmid-dependent phages to fight antibiotic resistance.
    Ojala V; Mattila S; Hoikkala V; Bamford JKh; Hiltunen T; Jalasvuori M
    Future Microbiol; 2016 Aug; 11():999-1009. PubMed ID: 27503765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy.
    Azam AH; Sato K; Miyanaga K; Nakamura T; Ojima S; Kondo K; Tamura A; Yamashita W; Tanji Y; Kiga K
    Microbiol Spectr; 2024 Jun; 12(6):e0042723. PubMed ID: 38695573
    [No Abstract]   [Full Text] [Related]  

  • 13. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
    Kamal F; Dennis JJ
    Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of novel phages for control of multi-drug resistant Escherichia coli O177 on artificially contaminated beef and their potential to disrupt biofilm formation.
    Montso PK; Mlambo V; Ateba CN
    Food Microbiol; 2021 Apr; 94():103647. PubMed ID: 33279072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance.
    Zuo P; Yu P; Alvarez PJJ
    Appl Environ Microbiol; 2021 Jul; 87(15):e0046821. PubMed ID: 34020940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Plasmids Reduce Permissivity to Coliphage Infection.
    Montelongo Hernandez C; Putonti C; Wolfe AJ
    Microbiol Spectr; 2023 Aug; 11(4):e0130923. PubMed ID: 37409956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
    Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M
    Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of bacteriophages against E.coli urinary tract infection and evaluating their anti-biofilm activity and antibiotic synergy.
    Devi B A; K V L; Sugumar S
    Microb Pathog; 2024 Aug; 193():106789. PubMed ID: 38972365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.